Skip to main content

Year: 2022

Agora Teams with HTC and Magic Leap Ahead of Immerse Global Summit   

At this year’s conference, Agora will demo new products that will deliver immersive metaverse experiences to enterprises, developers and end-users across the globe SANTA CLARA, Calif., Dec. 05, 2022 (GLOBE NEWSWIRE) — Agora, Inc. (NASDAQ: API), a pioneer and leading platform for real-time engagement APIs, today announced it will team with partners HTC, a global innovator in smart mobile devices and technology, and Magic Leap, an enterprise-grade AR technologies leader. The partnerships will showcase the power of real-time engagement and XR innovations across all sectors in Augmented Reality (AR) in education, industrial Internet of Things (IIOT), telehealth and more. These collaborations will be showcased at this year’s Immerse Global Summit, set to take place from December 5 to 7 at the Fontainebleau Hotel in Miami, Florida. The...

Continue reading

Hepion Pharmaceuticals Announces Early Completion of Enrollment in Phase 2 ‘ALTITUDE-NASH’ Liver Function Trial

– Hepion Enrolls 60 F3 NASH Subjects in only 12 weeks, facilitated by AGILE 3+ non-invasive test – – Hepion, Summit Clinical Research, and HepQuant Align to Deliver Rencofilstat’s Hepatic Function and NASH Biomarker Results by Q2, 2023 – EDISON, N.J., Dec. 05, 2022 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for the treatment of fibrotic diseases, including non-alcoholic steatohepatitis (“NASH”), hepatocellular carcinoma (“HCC”), and other chronic diseases, today announced that it has completed enrollment of 60 NASH stage 3 (“F3”) subjects in the Phase 2 ALTITUDE-NASH clinical trial. The trial is being conducted in collaboration with HepQuant, LLC (“HepQuant”) and Summit Clinical Research (“Summit”),...

Continue reading

Verizon continues to deploy 5G Ultra Wideband faster than expected

5G Ultra Wideband now available to more than 175 million people NEW YORK, Dec. 05, 2022 (GLOBE NEWSWIRE) — Verizon now covers more than 175 million people with their ultra fast, ultra reliable 5G Ultra Wideband service, and will offer nationwide 5G Ultra Wideband in Q1 2023. The ongoing C-Band rollout is a full 13 months ahead of the original schedule, and continues to accelerate. Less than 21 months after announcing the results of the FCC’s C-band auction and after securing early access to an additional 30 markets this year, Verizon accelerated its build plan and surpassed its goal of reaching 175 million people covered by the end of 2022, a month ahead of schedule. “Our customers don’t stand still and neither does our network. Today, more than one out of every two Americans now have access to 5G Ultra Wideband. We know our customers...

Continue reading

KRTL and Yuhan to Begin the Development of Products Between Korea and the US

Lakewood, CO, Dec. 05, 2022 (GLOBE NEWSWIRE) — KRTL Holding Group, Inc. (OTC: KRTL) an innovator and pioneer in developing industry leading cross-over tradecraft and proprietary technology and methodology in the hemp, cannabis, psilocybin, and alternative wellness sectors, is pleased to announce that its wholly owned subsidiaries, KRTL International Corp and KRTL Biotech Inc. (“KRTL”), have entered into a memorandum of understanding (MOU) for the development of industry-differentiated commercial CBD and other cannabinoid based products with Yuhan Care, a subsidiary of Yuhan Corporation, a global pharmaceutical company founded in 1926. Inspired by the hardship that their founder Dr. Ilhan witnessed under Japanese Imperialism, Yuhan Corporation was started with the belief that only healthy people could reclaim their sovereignty and...

Continue reading

Definitive Healthcare named a 2022 Top Place to Work by The Boston Globe for sixth consecutive year

FRAMINGHAM, Mass., Dec. 05, 2022 (GLOBE NEWSWIRE) — Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced it has been named one of the Top Places to Work in Massachusetts by The Boston Globe. Definitive Healthcare has now been recognized by The Boston Globe for a sixth consecutive year. “We’re honored to be recognized by The Boston Globe as a Top Place to Work for the sixth consecutive year,” said Robert Musslewhite, Chief Executive Officer at Definitive Healthcare. “As we expand our business, maintaining an inclusive and welcoming employee culture is a top priority. At Definitive Healthcare, we invest in leadership, career, and professional development opportunities to ensure that we retain and engage a world-class team. This recognition by The Boston Globe is a testament...

Continue reading

Mirasol Resources Announces Private Placement Financing

VANCOUVER, British Columbia, Dec. 05, 2022 (GLOBE NEWSWIRE) — Mirasol Resources Ltd. (TSX-V: MRZ) (OTCPK: MRZLF) (the “Company” or “Mirasol”) today announced it has arranged a non-brokered private placement financing (the “Offering”) of up to 5,000,000 common shares (the “Shares”) at a price of $0.60 per share for aggregate gross proceeds up to approximately $3.0M. The net proceeds of the Offering will be used to further Mirasol’s successful exploration programs and for general corporate purposes. Finders’ fees may be payable on a portion of the Offering. The shares issued under the Offering will be subject to a four month hold period. The Offering is subject to customary closing conditions, including approval from the TSX.V. This press release is not an offer of common shares for sale in the United States. The Shares may not be...

Continue reading

Allied Corp Successfully Executes on Another Sale & Export of Colombian Produced Cannabis Flower

KELOWNA, British Columbia, Dec. 05, 2022 (GLOBE NEWSWIRE) — Allied Corp. (“Allied” or the “Company”) (OTCQB: ALID) is pleased to announce that is has completed another sales transaction regarding the sell through of another 200kgs of cannabis flower. Allied only sells cannabis flower to jurisdictions where is it legal to do so. In June 2022, Allied was the first company to export cannabis flower from Colombia. Along with this shipment of 200kgs, Allied’s shipments of 272kgs, 200kgs, 1728kgs and 3425kgs have shown an established supply chain at commercial scale. In addition to this, Allied has now harvested two successful THC based flower harvests and is in the process of selling through that flower. Allied’s clients and supply channel partners span five (5) world continents that include Australia, Europe, Asia, South...

Continue reading

NBT Bancorp and Salisbury Bancorp Announce Agreement to Merge

Natural Extension into Attractive Contiguous Markets with High-Quality Partner Additional Scale in Combined Connecticut Footprint Expansion into Hudson Valley Region of Upstate New York’s “Chip Corridor” Immediate Market Premium to Salisbury Shareholders and an approximate 40% dividend improvement; Strong Earnings Accretion to Combined Shareholder Base Benefits of Additional Scale and Operating Leverage; Complementary Wealth Advisory Businesses and Increased Fee-Based Revenue Consistent Business Models and Strong Cultural AlignmentNORWICH, N.Y. and LAKEVILLE, Conn., Dec. 05, 2022 (GLOBE NEWSWIRE) — NBT Bancorp Inc. (NBT) (NASDAQ: NBTB) and Salisbury Bancorp, Inc. (Salisbury) (NASDAQ: SAL) announced today that they have entered into a definitive agreement pursuant to which Salisbury will merge with and into NBT. The merger consideration...

Continue reading

Ekso Bionics Announces Acquisition of Human Motion and Control Business Unit Including Indego® Product Line From Parker Hannifin Corporation

Broadens Ekso Bionics’ product portfolio into home use Adds Vanderbilt University as a key commercial and research partner Acquisition consolidates leading lower extremity robotic companies Ekso President and COO Scott Davis promoted to Chief Executive Officer; Steven Sherman to remain Chairman, appointed Executive Chair SAN RAFAEL, Calif., Dec. 05, 2022 (GLOBE NEWSWIRE) — Ekso Bionics (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced the acquisition of the Human Motion and Control (“HMC”) Business Unit from Parker Hannifin Corporation (“Parker”), a global leader in motion and control technologies. The acquisition includes the Indego lower limb exoskeleton line of products as well as the planned development of robotic assisted orthotic and prosthetic devices. This...

Continue reading

Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of November 30, 2022

Press ReleaseVELIZY-VILLACOUBLAY, France — December 5, 2022 Declaration of the number of outstanding shares and voting rights as of November 30, 2022 Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced below the total number of its outstanding shares and voting rights as of November 30, 2022, according to articles 223-16 and 221-3 of the General Regulation of the Autorité des marchés financiers. Number of outstanding shares: 1,334,891,109 Number of voting rights*: 2,033,581,125 *The total number of voting rights is calculated on the basis of the total number of outstanding shares, even if the voting rights attached thereto are suspended, pursuant to Article 223-11 of the General Regulation of the Autorité des marchés financiers relating to the method for calculating the percentages of holdings in shares and in voting...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.